|
Match
|
Document |
Document Title |
|
|
US20090258868 |
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
Disclosed are compounds of the formula I
or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein
W is a bond, —C(═S)—, —S(O)—, —S(O) 2...
|
|
|
US20090257968 |
Gels containing anionic surfactants and coupling agents
The present invention provides an enhanced gelling agent composition comprising a mixture of an anionic surfactant and a coupling agent. The invention also describes compositions in gel form...
|
|
|
US20090253763 |
ESTER COMPOUND AND ITS USE
An ester compound represented by the formula (I):
(wherein, R 1 represents a C1-C3 alkyl group, a 2-propenyl group or a 2-propynyl group.)
has excellent pest controlling activity and is...
|
|
|
US20090239888 |
Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation
Compositions and uses of mGluR 5 antagonists for the treatment and inhibition of amyloid precursor protein (APP), Aβ protein, and APP proteolytic products in Alzheimer's disease, Fragile X...
|
|
|
US20090220559 |
Multifunctional Solid Formulations for Water Conditioning
Solid formulations for use in water conditioning of circulating reservoirs, processes of preparing same and methods for water conditioning utilizing same are disclosed. The solid formulations...
|
|
|
US20090215846 |
(2,5-DIOXOIMIDAZOLIDIN-I-YL)-N-HYDROXY-ACETAMIDES AS METALLOPROTEINASE INHIBITORS
The invention provides compounds of the formula (I) wherein the variables are as defined in the specification. The compounds of the invention are inhibitors of metalloproteinase MMP-12 and are...
|
|
|
US20090186882 |
CGRP RECEPTOR ANTAGONISTS
The present invention relates to CGRP receptor antagonists, pharmaceutical compositions thereof, and methods therewith for treating CGRP receptor-mediated diseases and conditions.
|
|
|
US20090155385 |
METHODS OF REDUCING OR ELIMINATING SALMONELLA IN REPTILES AND/OR THEIR EGGS
A method for reducing or eliminating Salmonella in reptiles and/or reptile eggs through the use of at least one N,N-dihalo-5,5-dialkylhydantoin in which each of the alkyl groups is independently...
|
|
|
US20090149522 |
Method of preserving a customised composition
The invention concerns a process for producing a preserved customised consumer composition, preferably from a Vending machine, wherein a plurality of ingredient streams are mixed together in...
|
|
|
US20090149417 |
Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors
The present invention provides compositions of matter, kits and methods for their use in the treatment of cancer. In particular, the invention provides compositions and methods for treating cancer...
|
|
|
US20090117202 |
Formulations Containing a Non-Oxidative Biocide and a Source of Active Halogen and Use Thereof In Water Treatment
Novel formulations containing a non-oxidative biocide, such as DBNPA, and a source of an in situ produced active biocide, such as a concentrated aqueous solution of an inorganic halide salt, are...
|
|
|
US20090105323 |
TREATMENT OF EDIBLE CROPS
In the growing of crops for consumption, a method for the removal of pathogens includes the addition to irrigation water for the crops of an anti-pathogen composition and supplying the...
|
|
|
US20090076045 |
Non-nucleoside reverse transcriptase inhibitors
Compounds of formula I, wherein R 1 , X 1 , X 2 and A, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention...
|
|
|
US20090012066 |
Method of Use of Deacetylase Inhibitors
The present invention provides methods of treating and/or preventing pathologic cardiac hypertrophy and heart failure comprising administering hydroxamate compounds which are deacetylase inhibitors.
|
|
|
US20080318987 |
METHODS FOR MODULATING BONE FORMATION AND MINERALIZATION
Methods and compositions for modulating bone formation and mineralization are described.
|
|
|
US20080234204 |
Methods for evaluating and implementing prostate disease treatments
Provide is a method for evaluating test agents as candidates for treating prostatic diseases, including benign prostatic hyperplasia (BPH) and androgen dependent and androgen independent prostate...
|
|
|
US20080226618 |
HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS
This invention relates to compounds of the Formula (I),
or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which is useful for the treatment of diseases or conditions...
|
|
|
US20080221181 |
COMPOUNDS FOR TREATING TUMORS
The invention provides compounds of formula (I):
wherein E, A, B′, R 6 , R 7 , R 8 , and R 9 are defined in the specification which compounds exhibit anticancer activity and are useful for...
|
|
|
US20080200445 |
Heterocyclic aspartyl protease inhibitors
Disclosed are compounds of the formula I
or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein
W is a bond, —C(═S)—, —S(O)—, —S(O) 2...
|
|
|
US20080118553 |
Tannate salt form of polypeptide mixtures, their preparation and use
The subject invention provides a composition comprising a mixture of polypeptides in the form of a tannate salt wherein each polypeptide is a copolymer of the amino acids L-glutamic acid,...
|
|
|
US20080114057 |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE MUCOSAE, SKIN AND THE EYE
The present invention relates to compositions comprising a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory condition of the skin including, but...
|
|
|
US20080114032 |
Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
The present invention relates to the use of 1-ar(alk)ylimidazolin-2-ones which contain a disubstituted amine radical in the 4-position for the treatment or prevention of central nervous system...
|
|
|
US20080107701 |
Solid composition for treating water
Solid water treatment compositions are provided comprising (a) a halogen-containing source; (b) a boron-containing source; and (c) a polyphosphate-containing source. Methods for their use are also...
|
|
|
US20080096923 |
Methods For Diagnosing And Treating Diabetic Microvascular Complications
The present invention relates to a method for treating one or more diabetic microvascular complications in a patient in need of said treatment comprising: (a) diagnosing the severity of at least...
|
|
|
US20080085893 |
MATRIX METALLOPROTEASE INHIBITORS
The present invention relates to compounds of Formula I,
wherein R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. In addition, the present invention relates to methods treating...
|
|
|
US20080081052 |
Topical compositions containing solubilized allantoin and related methods
A method for enhancing solubility of allantoin in an aqueous vehicle using a solubilization enhancer is described. Aqueous compositions containing the solubilized allantoin at a level of 0.5% by...
|
|
|
US20080076809 |
Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses
The invention relates to a composition for caring for or making up keratinous fibers comprising a heterocyclic compound of formula (I) or of one of its salts:
in which: Hy is a heterocycle of...
|
|
|
US20080076778 |
METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF
The present invention relates to a computer-assisted method of a designing of a PARP inhibitor comprising: a) determining an interaction between a candidate PARP protein and a known PARP inhibitor...
|
|
|
US20080069791 |
Means for stimulation and activation of hair growth by il-15
The present invention relates to the use of IL-15 polynucleotides, polypeptides or compounds which bind to an antibody which specifically recognizes the IL-15 polypeptide or which specifically bind...
|
|
|
US20080039320 |
Use Of Menadione
The use of menadione or one of its plant-compatible acid addition salts for enhancing the activity of agrochemicals against phytopathogenic fungi, mixtures of menadione and at least one active...
|
|
|
US20080038303 |
Novel Solid Compositions for Disinfected Water
The present invention provides a method for the preparation of water-sanitizing solid, shaped compositions, said method comprising the steps of: mixing a halogenated 5,5-dimethylhydantoin compound...
|
|
|
US20080026077 |
METHODS AND COMPOSITIONS OF GENE DELIVERY AGENTS FOR SYSTEMIC AND LOCAL THERAPY
A method is provided for the delivery of a therapeutic to epithelial cells through the use of a bile acid conjugated to a peptide, the peptide being ionically charged at physiological pH. The...
|